High-tech investors pump $2.8 million into bio-tech Angels Investments place vote of confidence in BiondVax universal flu vaccine.
Universal flu vaccine shows positive independent results BiondVax Pharmaceuticals says study shows effective immunogenicity against H3N2 epidemic.